• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑递送中的天然多糖载体:挑战与展望

Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective.

作者信息

Curcio Manuela, Cirillo Giuseppe, Rouaen Jourdin R C, Saletta Federica, Nicoletta Fiore Pasquale, Vittorio Orazio, Iemma Francesca

机构信息

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.

Lowy Cancer Research Centre, Children's Cancer Institute, UNSW Sydney, Sydney 2031, NSW, Australia.

出版信息

Pharmaceutics. 2020 Dec 6;12(12):1183. doi: 10.3390/pharmaceutics12121183.

DOI:10.3390/pharmaceutics12121183
PMID:33291284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762150/
Abstract

Targeted drug delivery systems represent valuable tools to enhance the accumulation of therapeutics in the brain. Here, the presence of the blood brain barrier strongly hinders the passage of foreign substances, often limiting the effectiveness of pharmacological therapies. Among the plethora of materials used for the development of these systems, natural polysaccharides are attracting growing interest because of their biocompatibility, muco-adhesion, and chemical versatility which allow a wide range of carriers with tailored physico-chemical features to be synthetized. This review describes the state of the art in the field of targeted carriers based on natural polysaccharides over the last five years, focusing on the main targeting strategies, namely passive and active transport, stimuli-responsive materials and the administration route. In addition, in the last section, the efficacy of the reviewed carriers in each specific brain diseases is summarized and commented on in terms of enhancement of either blood brain barrier (BBB) permeation ability or drug bioavailability in the brain.

摘要

靶向给药系统是增强治疗药物在大脑中蓄积的重要工具。在此,血脑屏障的存在严重阻碍了外来物质的通过,常常限制了药物治疗的效果。在用于开发这些系统的大量材料中,天然多糖因其生物相容性、粘膜粘附性和化学多功能性而越来越受到关注,这些特性使得能够合成具有定制物理化学特性的多种载体。本综述描述了过去五年基于天然多糖的靶向载体领域的研究现状,重点关注主要的靶向策略,即被动和主动转运、刺激响应材料以及给药途径。此外,在最后一部分,对所综述的载体在每种特定脑部疾病中的疗效进行了总结,并就其增强血脑屏障(BBB)渗透能力或脑部药物生物利用度方面进行了评论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/4e96d2273445/pharmaceutics-12-01183-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/d18693a8e93a/pharmaceutics-12-01183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/443a955276aa/pharmaceutics-12-01183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/e15b6ea9c5cd/pharmaceutics-12-01183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/959efb1e6602/pharmaceutics-12-01183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/c6d429d0b739/pharmaceutics-12-01183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/6d07c4c73423/pharmaceutics-12-01183-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/4e96d2273445/pharmaceutics-12-01183-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/d18693a8e93a/pharmaceutics-12-01183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/443a955276aa/pharmaceutics-12-01183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/e15b6ea9c5cd/pharmaceutics-12-01183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/959efb1e6602/pharmaceutics-12-01183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/c6d429d0b739/pharmaceutics-12-01183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/6d07c4c73423/pharmaceutics-12-01183-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/4e96d2273445/pharmaceutics-12-01183-g007.jpg

相似文献

1
Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective.脑递送中的天然多糖载体:挑战与展望
Pharmaceutics. 2020 Dec 6;12(12):1183. doi: 10.3390/pharmaceutics12121183.
2
In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.静脉注射后,朊病毒和 GM1 靶向聚合物囊泡在小鼠体内的生物分布。
Mol Pharm. 2012 Jun 4;9(6):1620-7. doi: 10.1021/mp200621v. Epub 2012 May 7.
3
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.脂质纳米粒策略修饰脑靶向药物的药代动力学:穿越或绕过血脑屏障(BBB)以治疗神经疾病。
Adv Drug Deliv Rev. 2022 Oct;189:114485. doi: 10.1016/j.addr.2022.114485. Epub 2022 Aug 12.
4
Micro-Nanocarriers Based Drug Delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy.基于微纳米载体的药物递送技术用于血脑屏障穿越和脑肿瘤靶向治疗
Small. 2022 Nov;18(45):e2203678. doi: 10.1002/smll.202203678. Epub 2022 Sep 14.
5
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.多功能纳米载体用于血脑屏障的诊断、药物输送和靶向治疗:追踪和神经影像学的观点。
Part Fibre Toxicol. 2010 Mar 3;7:3. doi: 10.1186/1743-8977-7-3.
6
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.近期在纳米脂质载体的制备及其脑靶向应用方面的策略和进展。
J Control Release. 2020 May 10;321:372-415. doi: 10.1016/j.jconrel.2020.02.020. Epub 2020 Feb 12.
7
Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.基于碳水化合物的聚合物的抗癌药物传递。
Curr Pharm Des. 2018 Feb 12;23(39):6019-6032. doi: 10.2174/1381612823666170505124927.
8
Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides.多糖基纳米载体用于口服递蛋白/肽的研究进展与展望。
Carbohydr Polym. 2023 Jul 15;312:120838. doi: 10.1016/j.carbpol.2023.120838. Epub 2023 Mar 24.
9
Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview.用于增强药物透过血脑屏障递送的聚合物纳米载体制造新策略:综述。
Adv Colloid Interface Sci. 2023 Oct;320:103008. doi: 10.1016/j.cis.2023.103008. Epub 2023 Sep 26.
10
Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols.基于海洋多糖的多功能纳米载体用于食品多酚的结肠递药研究进展
J Agric Food Chem. 2022 Feb 2;70(4):903-915. doi: 10.1021/acs.jafc.1c05012. Epub 2022 Jan 24.

引用本文的文献

1
Rational Design of Pectin-Chitosan Polyelectrolyte Nanoparticles for Enhanced Temozolomide Delivery in Brain Tumor Therapy.用于脑肿瘤治疗中增强替莫唑胺递送的果胶-壳聚糖聚电解质纳米颗粒的合理设计
Biomedicines. 2024 Jun 23;12(7):1393. doi: 10.3390/biomedicines12071393.
2
Micro- and Nanostructured Fibrous Composites via Electro-Fluid Dynamics: Design and Applications for Brain.通过电流体动力学制备的微纳结构纤维复合材料:用于脑部的设计与应用
Pharmaceutics. 2024 Jan 19;16(1):134. doi: 10.3390/pharmaceutics16010134.
3
Hyaluronic Acid Conjugated with 17β-Estradiol Effectively Alleviates Estropause-Induced Cognitive Deficits in Rats.

本文引用的文献

1
Carboxymethyl cellulose coated magnetic nanoparticles transport across a human lung microvascular endothelial cell model of the blood-brain barrier.羧甲基纤维素包被的磁性纳米颗粒跨血脑屏障的人肺微血管内皮细胞模型转运。
Nanoscale Adv. 2018 Oct 16;1(2):671-685. doi: 10.1039/c8na00010g. eCollection 2019 Feb 12.
2
Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers.突破血脑屏障:功能化壳聚糖纳米载体
Pharmaceutics. 2020 Oct 23;12(11):1013. doi: 10.3390/pharmaceutics12111013.
3
Synthesis and characterization of novel chitosan-dopamine or chitosan-tyrosine conjugates for potential nose-to-brain delivery.
透明质酸与 17β-雌二醇缀合物有效缓解去势大鼠认知功能障碍。
Int J Mol Sci. 2023 Oct 25;24(21):15569. doi: 10.3390/ijms242115569.
4
Polysaccharide-Based Nanogels to Overcome Mucus, Skin, Cornea, and Blood-Brain Barriers: A Review.基于多糖的纳米凝胶克服黏液、皮肤、角膜和血脑屏障的研究综述
Pharmaceutics. 2023 Oct 23;15(10):2508. doi: 10.3390/pharmaceutics15102508.
5
Facile one-pot hydrothermal synthesis of a zinc oxide/curcumin nanocomposite with enhanced toxic activity against breast cancer cells.一种氧化锌/姜黄素纳米复合材料的简便一锅水热合成法,其对乳腺癌细胞具有增强的毒性活性。
RSC Adv. 2023 Sep 11;13(39):27180-27189. doi: 10.1039/d3ra05176e. eCollection 2023 Sep 8.
6
Preparation and Characterization of Hydrogel Films and Nanoparticles Based on Low-Esterified Pectin for Anticancer Applications.基于低酯化度果胶的水凝胶薄膜和纳米颗粒的制备及其在抗癌应用中的表征
Polymers (Basel). 2023 Aug 2;15(15):3280. doi: 10.3390/polym15153280.
7
The blood-brain barrier: structure, regulation, and drug delivery.血脑屏障:结构、调控与药物递送。
Signal Transduct Target Ther. 2023 May 25;8(1):217. doi: 10.1038/s41392-023-01481-w.
8
Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.源自肠道微生物群和益生菌的膜囊泡:针对与神经异常相关的多重耐药超级细菌的前沿治疗方法。
Pharmaceutics. 2022 Nov 3;14(11):2370. doi: 10.3390/pharmaceutics14112370.
9
Crosslinked Chitosan-Gelatin Biocompatible Nanocomposite as a Neuro Drug Carrier.交联壳聚糖-明胶生物相容性纳米复合材料作为神经药物载体
ACS Omega. 2022 May 26;7(22):18732-18744. doi: 10.1021/acsomega.2c01443. eCollection 2022 Jun 7.
10
Polymeric Biomaterials for the Treatment of Cardiac Post-Infarction Injuries.用于治疗心肌梗死后损伤的聚合物生物材料。
Pharmaceutics. 2021 Jul 7;13(7):1038. doi: 10.3390/pharmaceutics13071038.
新型壳聚糖-多巴胺或壳聚糖-酪氨酸缀合物的合成与表征及其用于潜在的经鼻脑递药。
Int J Pharm. 2020 Nov 15;589:119829. doi: 10.1016/j.ijpharm.2020.119829. Epub 2020 Aug 30.
4
A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier.壳聚糖修饰纳米颗粒穿越血脑屏障的再评估
Membranes (Basel). 2020 Aug 30;10(9):212. doi: 10.3390/membranes10090212.
5
Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat Glioblastoma.用于优化紫杉醇递送以治疗胶质母细胞瘤的肿瘤响应性和可调谐聚合物平台。
ACS Appl Mater Interfaces. 2020 Apr 29;12(17):19345-19356. doi: 10.1021/acsami.0c04102. Epub 2020 Apr 17.
6
Engineering butylglyceryl-modified polysaccharides towards nanomedicines for brain drug delivery.将丁基甘油基改性多糖工程化用于脑部药物递送的纳米医学。
Carbohydr Polym. 2020 May 15;236:116060. doi: 10.1016/j.carbpol.2020.116060. Epub 2020 Feb 21.
7
RETRACTED: Quantification and Evaluations of Catechin Hydrate Polymeric Nanoparticles Used in Brain Targeting for the Treatment of Epilepsy.撤回:用于脑靶向治疗癫痫的儿茶素水合物聚合物纳米颗粒的定量与评估
Pharmaceutics. 2020 Feb 27;12(3):203. doi: 10.3390/pharmaceutics12030203.
8
Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances.纳米载体作为治疗神经退行性疾病中克服血脑屏障的有力工具:聚焦于近期进展
Asian J Pharm Sci. 2019 Sep;14(5):480-496. doi: 10.1016/j.ajps.2018.09.005. Epub 2018 Oct 22.
9
Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain.经鼻给药载有卡马西平的羧甲基壳聚糖纳米粒用于药物向脑内递送
Asian J Pharm Sci. 2018 Jan;13(1):72-81. doi: 10.1016/j.ajps.2017.09.001. Epub 2017 Sep 12.
10
Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.载罗替戈汀壳聚糖纳米粒经鼻向脑递药在人 SH-SY5Y 神经母细胞瘤细胞和帕金森病动物模型中的研究
Int J Pharm. 2020 Apr 15;579:119148. doi: 10.1016/j.ijpharm.2020.119148. Epub 2020 Feb 19.